New England Innovation Society
 

gwen burlingame, CO-FOUNDER, BECKON ICE CREAM 

Gwen Burlingame is Co-Founder of Beckon, the first and only premium, lactose-free dairy ice cream on the market.  Originally from Springfield, VA, Gwen is a graduate of Villanova University, where she studied Marketing and International Business. 

Prior to co-founding Beckon, Gwen held roles at L’Oreal USA in e-commerce and digital strategy for Luxe Division, International Business development for Kiehl’s Since 1851 and Global Brand Marketing, also at Kiehl’s, managing the Lip and Sun product portfolios. 

Beckon Ice Cream (Minus-the-Moo at the time) was a 2018 New England Innovation Award Winner.

 

DEBORA BABIN KATZ, VICE PRESIDENT, TRUCBRUSH CORPORATION

Debora Babin Katz is VP of TrucBrush Corporation headquartered in Easton, MA.  Katz oversees manufacturing, marketing and distribution of its mobile attachment to clear snow off truck, trailer, bus, intermodal container rooftops, flatbeds and step decks.

Debora also services as board chair of Women In Trucking Foundation, a 501 (c3) non-profit providing educational scholarships to women in four transportation categories: driving, safety, technical and leadership.  Since serving as chair, the Foundation has more than tripled its scholarship funding.  Debora is executive secretary and board member of Trucking Assoc. of MA (TAM), and a board member of national Snow & Ice Management Assoc. (SIMA).  In 2015, she was recognized with SIMA Volunteer of the Year award for ten years of commitment, including chairing the editorial advisory committee of Snow Business Magazine.

A graduate of Babson College, Debora is an entrepreneur, published writer and expert in business development and marketing.  In 2006, she established her own marketing firm, d.communications, llc, which she operated successfully until 2013.  That year, a colleague in the industry introduced her to Jim Burns of Fairway Lawn Care Corporation.  Jim had an idea for a new snow product that could effectively and safely clear fleet rooftops.  “I knew this would be a ‘game changer’ in the industry and I wanted to be a part of its story,” said Debora.  In 2016, TrucBrush Corp. received NEBA’s ‘Rising Star’ Innovation Award and SIMA’s Snow Industry Commitment award for outstanding innovation and customer service.  By 2017 the Company received a global endorsement from Caterpillar.   Debora's story is one of passion, purpose and true leadership grit.

EVAN BUTLER, CEO, ETIOMETRY, Inc.

 

Evan Butler is an engineer and entrepreneur who co-founded Etiometry in 2010. Previously, he worked at Boston Children’s Hospital in the Pediatric Cardiac Bioengineering Laboratory designing, building, and testing novel surgical robots and tools. Evan was also a NASA GSRP Fellow with Dryden Flight Research Center, and created intelligent flight control systems.

He received his Bachelor’s degree in Physics and Aerospace Engineering, and his Masters degree in Dynamics and Control Engineering from Boston University. Evan has published conference papers, journal articles and a book chapter in the fields of medical predictive analytics, concentric tube robots and tools for minimally-invasive beating heart surgery, and intelligent flight control systems. Evan has received multiple awards, including the 2010 IEEE Transactions on Robotics Best Paper Award.

Etiometry was a 2018 New England Innovation Award Winner.

 

 KEITH COOPER, CEO, REVOLUTIONARY CLINICS 

 

Keith Cooper is a successful entrepreneur with more than 30 years running VC-backed technology companies.  He is currently CEO of Revolutionary Clinics (RC), a leading medicinal cannabis company in MA.  RC has an active cultivation and processing facility in Fitchburg, retail locations in Cambridge and Somerville and a home delivery business.

Prior to RC, Keith was CEO of Constant Therapy (CT), a company revolutionizing the treatment of neurological disorders using science-based digital therapy on mobile devices.  CT was acquired by a Private Equity firm in 2017. Prior to CT, Keith was CEO of Connotate (web Big Data aggregation), President of Carbonite (#9 on the Inc. 500 list, Best Places to Work in Boston, Most Innovative Companies in New England,NASDAQ:CARB), CEO of webHancer (acquired by Microsoft), CEO of FaxNet (acquired by Critical Path) and GM of Trans National Communications (#12 on the Inc. 500 list).

A graduate of Harvard Business School (1988) and Harvard College (1983, President of the Harvard Rugby Club), Keith lives in Wayland, MA, is married and has two young adult sons.   

Carbonite was a 2010 New England Innovation Award Winner.

 DR. ANTHONY COSTON, HEAD OF MEDICAL DEVICES DIVISION, THE CHARLES STARK DRAPER   LABORATORY

 

Dr. Anthony F. Coston is the Head of Medical Devices at The Charles Stark Draper Laboratory, Inc. where he oversees the Medical Device Business within Draper’s Commercial Division. His daily New Business Development (NBD) activities involve determining how to leverage internal technologies and capabilities and deploy them against significant unmet needs within the Medical Device Marketplace through collaborations and partnerships with Commercial companies. 

Anthony's portfolio of available technologies and capabilities includes Neurotechnology, Mental Health, Diagnostics & Therapeutics, Data Analytics, and Image Processing. He holds a degree in Electrical Engineering from the University of Delaware, in Biomedical Engineering from Penn State University, a PhD in Biomedical Engineering from Rutgers University and MBA from MIT's Sloan School of Management.

 CAROLYN EDELSTEIN, EXECUTIVE DIRECTOR, OPENBIOME

Carolyn Edelstein is the Executive Director of OpenBiome, a universal stool bank and microbiome research institute, and a 2017 New England Innovation Award winner. Carolyn was a member of the founding team and previously served as Director of Outreach and Public Affairs, where she oversaw OpenBiome's efforts to expand the availability of FMT across 1,000 hospitals and clinics, present its work to the public, and contribute to the discourse on the regulation of fecal microbiota.

Previously, Carolyn worked at the US Agency for International Development, where she helped launch the Global Innovation Fund, a $200 million institution backed by foreign aid agencies from the US, UK, Canada, Australia, Sweden, and South Africa to test and support low-cost, high-impact interventions to improve global health and prosperity.

Carolyn holds an MPA and a BA from Princeton University's Woodrow Wilson School of Public and International Affairs, where she was awarded the SINSI Fellowship.

OpenBiome was a 2017 New England Innovation Award Winner.

 

 KATY FLANERY, CO-FOUNDER, BECKON ICE CREAM

 

Katy Flannery is Co-Founder of Beckon, the first and only premium, lactose-free dairy ice cream on the market.  Originally from North Attleboro, MA, Katy is a graduate of Villanova University, where she studied Nursing. 

Katy was previously an RN in the Pediatric ICU at Boston Children’s Hospital.  It was her food journey and lactose intolerance that inspired Beckon and she is also a graduate of the famous Penn State Ice Cream Course.

Beckon Ice Cream (Minus-the-Moo) at the time, was a 2018 New England Innovation Award Winner.

 

PAUL HOLZER, CEO, XENOTHERAPEUTICS, INC.

 

Paul Holzer is CEO and co-founder of XenoTherapeutics, bringing 15 years in various leadership roles to the field of xenotransplantation. Paul served in four decorated combat deployments as an Officer in the United States Navy SEAL Teams, leaving in 2013 as a Lieutenant Commander. 

While pursuing his master’s degree in mechanical engineering, Paul trained under Dr. David Sachs and Dr. Curtis Cetrulo at Massachusetts General Hospital in the Transplantation Biology Research Center. Paul is a distinguished paramedic, having received The President’s Volunteer Service Award for leading a team of first responders to the Philippines following Typhoon Haiyan in 2013.

Paul is a founding board member and Treasurer of the New England Navy SEAL Foundation, and in 2015 was appointed by Massachusetts Governor Charlie Baker to serve as a Trustee of Bunker Hill Community College. He is a graduate of the University of Florida, the Massachusetts Institute of Technology, and Southern New Hampshire University.

XenoTherapeutics was a 2018 New England Innovation Award Winner. 

 

 ALEX KAMBANIS, PRESIDENT & MANAGING DIRECTOR, GET GROUP NORTH AMERICA

Alex is an Identity Solutions expert and for over 15 years has enabled Governments around the world implement new technologies around secure Government Credentials (National IDs, Driver’s Licenses and Passports).

He is President & Managing Director of GET Group North America based in Waltham MA, which was recently awarded a contract by the US Department of State for the implementation of the Next Generation US Passport. Alex believes that mobile identity is the foundation of any effective digital security strategy and has recently directed the company’s efforts towards the development of its new globally interoperable mobile drivers’ licenses technology.

Alex serves on the Board of the Document Security Alliance, an association of government, industry and academia dedicated to securing the production, issuance, and authentication of identity, credentials, and currency.

 

JON LIEBER, MANAGING DIRECTOR, DANFORTH ADVISORS, LLC.

Jon Lieber currently serves as a Managing Director at Danforth Advisors.   He has 25 years of experience in financial and executive management at emerging and growth-stage life science companies and in investment banking. During his tenure as a CFO, he has raised more than $300 million of equity and debt in public and private securities offerings and led strategic and business development transactions. He most recently served as CFO of Histogenics Corporation (New England Innovation Award Winner 2017). 

Prior to Histogenics he held additional CFO roles including:  Metamark Genetics, Inc. Repligen Corporation, Xcellerex, Inc.(acquired by GE Healthcare) and Altus Pharmaceuticals, Inc. Previously, Jon was an investment banker for 10 years, during which time he originated and executed on numerous corporate financings and merger and acquisition transactions at SG Cowen and Salomon Brothers Inc. He received a BS in Business Administration and Finance from Boston University and an MBA in Finance from New York University Stern School of Business.

Histogenics was a 2017 New England Innovation Award Winner.

 

JUAN LOPERA, MARKETING & DEVELOPMENT VP, PUBLIC PLANS AND CORPORATE BUSINESS DIVERSITY OFFICER, TUFTS HEALTH PLAN

Juan is responsible for business development, marketing and community relations for all products offered by Tufts Health Plan’s public plans division across Massachusetts and Rhode Island. He is also Corporate Business Diversity Officer, responsible for company-wide diversity efforts. Previously, Juan was the company’s director of health care services where he led medical cost management and provider contracting strategy and analytics. He also held management roles at Blue Cross Blue Shield and Deloitte Consulting.

He serves on several boards including Vice-Chair of the Dimock Center Board, The State of Massachusetts Latino Advisory Commission, The Boston Foundation Latino Legacy Fund, Quality Interactions Corporate Advisory Board and ConsejoSano's Advisory Board. Juan earned a B.S. from the School of Management at Boston College. He is originally from Medellin, Colombia and resides in Waltham, MA.

 

FRANK MCGILLIN, CHIEF COMMERCIAL OFFICER, NEUROMETRIX

Frank is Chief Commercial Officer at Neurometrix where he is leading the commercialization of a class of wearables with the launch of Quell™ Wearable Pain Relief Technology, an FDA cleared, 100% drug free alternative for managing chronic pain. After a successful crowdfunding campaign on Indiegogo in 2015, Quell is now available online and selected major US retailers including Amazon and CVS, Best. Quell has been covered extensively in national media including Good Morning America, CBS News, Forbes, Fortune, Wired and Men’s Health. Quell was the winner of the SXSW Innovation Award for Wearable Technology. 

Frank has over 20 years of experience building successful, high-growth consumer health and technology brands at Philips and Johnson & Johnson, launching over 50 new products and leading global expansion of Sonicare.  He has a passion for innovation in digital health.

NeuroMetrix was a 2017 New England Innovation Award Winner.

 

DR. RUPAL PATEL, FOUNDER & CEO, VOCALID 

With decades of clinical and research experience in personalized assistive communication technology, Dr. Patel champions the effort to bring VocaliD’s technology to the people who need it most. She is a tenured Professor at Northeastern University’s Bouvé College of Health Sciences.

A native of Canada, Dr. Patel received her B.Sc. in Psychology from University of Calgary and her Masters and PhD in Speech Language Pathology from the University of Toronto. She then completed her post-doctoral studies in speech acoustics at MIT. An internationally renowned expert in speech motor control and assistive communication technology, she has raised over $6M in research funding and her work has been featured on TED, NPR, Wall Street Journal, Wired, etc.

VocalID was a 2017 New England Innovation Award Winner.

 

CHRISTINA ROTH, CEO & FOUNDER, COLLEGE DIABETES NETWORK

Christina is the Chief Executive Officer and Founder of College Diabetes Network (CDN). Diagnosed with type 1 diabetes at age 14, Christina became an active patient advocate while in college where she started CDN as a campus group in 2009. Due to the overwhelming response to the initial group, Christina expanded CDN into a national non-profit organization serving young adults with diabetes. After graduation, Christina worked at the Joslin Diabetes Center and consulted for the T1D Exchange. 

As CEO of CDN, Christina frequently speaks on topics such as CDN’s programs, research on the young adult population and how to meet their unique needs, non-profit management, women in business, innovation, and start-up organizations. She also serves on the board of directors at the Diabetes Patient Advocacy Coalition (DPAC). 

College Diabetes Network was a 2017 New England Innovation Award Winner.

 

DR. PETER ROTHSCHILD, FOUNDER & CHIEF TECHNOLOGY OFFICER, VIKEN DETECTION

Dr. Rothschild is an entrepreneur and an inventor. He is author or coauthor of more than 50 issued and pending patents in the US, and the inventor of several novel x-ray techniques, including Scatter Attenuation Tomography. In the last five years he has started two successful companies: Viken Detection, which designs and manufactures state-of-the art handheld x-ray devices used in the environmental inspection and homeland security spaces and Vaucluse Partners, an algorithmic hedge fund that trades volatility derivatives. 

Peter received his undergraduate degree in physics and mathematics from the Australian National University and his Ph.D. in physics from MIT. Peter lives with his wife Kelly and two children in Newton, Massachusetts.

Viken Detection (Heuresis Corporation at the time) was a 2018 New England Innovation Award Winner.

 

 MICHAEL SCHMIDT, PRESIDENT , VENMILL INDUSTRIES, INC.

Mike started his career in marketing but after a few years found his real passion in helping struggling companies find new products or new markets.  Most recently Mike as the Founder and former President of SoClean, where he took the company from conception up through an acquisition well over $100 M. As President of a start up, he was involved with everything from product development and production, fulfillment and logistics, customer support and R&D. As the company expanded he hired additional personnel for key roles but continued to oversee R&D, product development, contract management and logistics. 

SoClean was a winner of the New England Innovation Award in 2017.  Following SoClean, Mike established CEO Flex, LLC to assist start-ups and entrepreneurs in taking their products to market.  The small team of dedicated people that enjoyed the success of SoClean is now working on other opportunities. 

 

KENNETH J. SMITH, CEO, BDC CAPITAL


Since 1984, Ken has served as the Chief Executive Officer of BDC Capital. From 1984-2018, Ken also served as the President of BDC Capital. During his tenure the company has grown from a small, single state lending operation to a six state, diversified loan and investment company with offices throughout New England. BDC Capital now manages several mezzanine investment funds, to compliment a broad array of small business loan programs that they have used to serve local area businesses for more than 50 years. BDC Capital now has more than $700 million in loans and investments to hundreds of companies throughout New England.

Ken is a graduate of the University of Massachusetts and Northeastern University and he has won numerous accolades over the years, including being named one of Boston’s Ten Outstanding Young Leaders. BDC Capital has been named the top performing Business Development Corporation in the country and is noted for its innovative programs for small business lending and investing.

 

 

 JEFFREY R. SWEET, VICE PRESIDENT & SENIOR LOAN OFFICER, TD BANK

Jeff joined TD Bank in December 2011 as a Relationship Manager/Senior Loan Officer after stints with Bank of Boston, Bank of New England and successor banks.  With over 30 years of commercial lending experience in Greater Boston, Jeff focuses on assisting privately held enterprises and commercial real estate investors with their commercial banking needs.

A graduate of Furman University and Bank of Boston's Loan Officer Development Program , he is a member of the Diversity Council at TD Bank and a Director of the New England Business Association. The father of three adult children, Jeff lives in Sharon, MA with his wife, Elisabeth.